Oxidation of synephrine by type A and type B monoamine oxidase

@article{Suzuki2005OxidationOS,
  title={Oxidation of synephrine by type A and type B monoamine oxidase},
  author={Osamu Suzuki and T. Matsumoto and Masakazu Oya and Yoshinao Katsumata},
  journal={Experientia},
  year={2005},
  volume={35},
  pages={1283-1284}
}
Synephrine (SP) was found to be a substrate for monoamine oxidase (MAO) in rat brain mitochondria, showing the Km and Vmax values of 250 μM and 32.6 nmoles/mg of protein/30 min respectively. The inhibition studies showed that the SP oxidation was carried out by both type A and type B MAO and a major part of the activity was due to type A MAO. 
Methoxyphenylethylamines as substrates for type A and type B monoamine oxidase
4-Methoxyphenylethylamine was found to be a specific substrate for type B monoamine oxidase (MAO) in rat brain mitochondria, whereas 3,4-dimethoxyphenylethylamine was common for both types of MAO.Expand
Fast hepatic biotransformation of p-synephrine and p-octopamine and implications for their oral intake.
TLDR
The rapid hepatic transformation of p-synephrine and p-octopamine means that their concentration in the portal vein exceeds that in the systemic circulation during absorption, and their metabolic effects will be exerted predominantly in the liver. Expand
Synephrine: from trace concentrations to massive consumption in weight-loss.
TLDR
The mechanisms involved in synephrine-induced cardiotoxicity are still unknown since studies related to its safety are scarce and this review will focus on the efficacy and toxicity aspects related to the use ofsynephrine in weight-loss. Expand
Interaction of p-synephrine on the pharmacodynamics and pharmacokinetics of gliclazide in animal models
TLDR
The effect of multiple dose p-synephrine treatments upon gliclazide appeared to be pharmacodynamic in nature, indicating the need for periodic monitoring of glucose levels and dose adjustment as necessary when this combination is prescribed to obese patients. Expand
Synephrine , Octopamine and Caffeine Health Risk Assessment ( HRA ) Report
Issue Assessment of the potential risks to health from natural health products containing synephrine and/or octopamine in combination with caffeine. various products not licensed for sale in CanadaExpand
Phytochemical compounds in sport nutrition: Synephrine and hydroxycitric acid (HCA) as examples for evaluation of possible health risks.
TLDR
Animal and human studies, as well as case reports, provide evidence for cardiovascular effects due to ingestion of high synephrine doses, especially in combination with caffeine and physical exertion, and substantial uncertainties exist regarding the safety of supplements containing high amounts of HCA. Expand
American Botanical Council Bitter Orange Peel and Synephrine
The announcement in late December by the U.S. Food and Drug Administration (FDA) that it intends to issue regulations banning the sale of dietary supplements containing the controversial herb ephedraExpand
Critical review of electrochemical advanced oxidation processes for water treatment applications.
  • B. Chaplin
  • Chemistry, Medicine
  • Environmental science. Processes & impacts
  • 2014
TLDR
Key challenges facing EAOP technologies are related to toxic byproduct formation and low electro-active surface areas and must be addressed in future research in order for EAOPs to realize their full potential for water treatment. Expand
Bitter Orange (Citrus aurantium var. amara) Extracts and Constituents (±)-p-Synephrine [CAS No. 94-07-5] and (±)-p-Octopamine [CAS No. 104-14-3] Review of Toxicological Literature
  • 2004
.......................................................................................................................................... i ExecutiveExpand
Potential Herb–Drug Interactions in the Management of Age-Related Cognitive Dysfunction
TLDR
Reviewing the potential interactions between selected bioactive compounds used by seniors for cognitive enhancement and representative drugs commonly prescribed to the middle-aged adults to anticipate and prevent risks arising from their co-administration finds interaction with other drugs affecting the same targets may be anticipated and prevented. Expand
...
1
2
...

References

SHOWING 1-10 OF 14 REFERENCES
Multiplicity of monoamine oxidase in chick brain
TLDR
It was found that neither 5-hydroxytryptamine nor β-phenylethylamine is the specific substrate for type A and type B MAO in chick brain. Expand
Beta-phenylethylamine: a specific substrate for type B monoamine oxidase of brain.
  • H. Y. Yang, N. Neff
  • Chemistry, Medicine
  • The Journal of pharmacology and experimental therapeutics
  • 1973
TLDR
It is concluded that the amines of brain may be cataboblized by specific types of monoamine oxidase in vivo. Expand
A kinetic evaluation of monoamine oxidase activity in rat liver mitochondrial outer membranes.
1. A preparation of mitochondrial outer membranes from rat liver can be shown to contain two kinetically distinct monoamine oxidase activities. These activities are distinguishable by their differentExpand
Some observations upon a new inhibitor of monoamine oxidase in brain tissue.
TLDR
The hypothesis that in the enzyme prepared, the MAO is a binary system of enzymes each of which has a detectably different sensitivity to this particular inhibitor, is put forward and evidence after dialysis supports this hypothesis. Expand
Biosynthesis of cerebral phenolic amines. I. In vivo formation of p-tyramine, octopamine, and synephrine.
TLDR
Differences in the amounts of the phenolicamines formed suggest that mechanisms other than just decarboxylation are involved in the formation of phenolic amines. Expand
The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
  • H. Y. Yang, N. Neff
  • Chemistry, Medicine
  • The Journal of pharmacology and experimental therapeutics
  • 1974
TLDR
It is postulate that it may be possible to alter selectively the metabolism of the putative transmitter amines in man by administration of monoamine oxidase inhibitor drugs that preferentially inactivate a specific type of monoamines. Expand
Identification of p-hydroxy-alpha-(methylaminomethyl) benzyl alcohol (synephrine) in human urine.
TLDR
Studies by a variety of procedures have definitely established its identity as p-hydroxy-oc-(methylaminomethyl)benzyl alcohol (synephrine, Sympatol), which suggested that the unknown base in urine was a derivative of p-Hydroxyphenylethanolamine. Expand
A simple and sensitive fluorescence assay for monoamine oxidase and diamine oxidase.
  • S. Snyder, E. Hendley
  • Chemistry, Medicine
  • The Journal of pharmacology and experimental therapeutics
  • 1968
TLDR
Diamine oxidase from rat small intestine oxidized putrescine, cadaverine, histamine and 1,4- methyl histamine, but appeared to have a greater affinity for histamine than for the other sub strates tested, while monoamine oxidase in rat brain and liver had the same relative activities toward a number of substrates. Expand
The phenolic amines of human urine.
TLDR
A simple procedure for concentrating, purifying, and detecting the free and conjugated phenolic amines in urine by adsorption on an ion exchange resin followed by two-dimensional paper chromatography is described. Expand
Trace amines and alternative neurotransmitters in the central nervous system.
TLDR
It is now apparent that its turnover in most neuronal tissues is very rapid, and based on the production of deaminated metabolites, the daily synthesis of octopamine in the whole body closely approaches that of the catecholamines. Expand
...
1
2
...